Bridge Investment Fund L.P. in Cleveland participated in a recent $5 million financing round for Navotek Medical Ltd. in Haifa, Israel. Navotek is developing a device that precisely locates tumors in the body so that they can be targeted by chemotherapy or radiation.

Dr. Roger Macklis, a radiation oncologist at the Cleveland Clinic and a medical advisor for Navotek, helped introduce the Israeli company to Bridge, said the venture capital firm's managing partner, Michael Goldberg.

Click here to read the entire story at Cleveland.com